Nouvelles Eulerpool Urogen Pharma

Urogen Pharma Actualités des actions

Urogen Pharma est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Urogen Pharma.

• 17 juin ·

  Yahoo
  H.C. Wainwright Sees Billion Dollar Potential in UroGen’s New Therapy
• 12 juin ·

  Yahoo
  U.S. FDA Approves UroGen’s ZUSDURI™ (mitomycin) for Intravesical Solution as the First and Only Medication for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
• 10 juin ·

  SeekingAlpha
  UroGen: Despite ODAC Vote, Hope Remains With Targeting Of Other  Cancer Subpopulation
• 6 juin ·

  Yahoo
  UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 2 juin ·

  Yahoo
  UroGen Announces Data at ASCO 2025 Annual Meeting on UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
• 24 mai ·

  SeekingAlpha
  Nvidia, Dell, Salesforce To Report Earnings Next Week
• 21 mai ·

  SeekingAlpha
  UroGen Pharma: ODAC Decision Puts Drug Approval In Limbo, But It's Not Over, Either
• 15 mai ·

  Yahoo
  UroGen Pharma Ltd. (NASDAQ:URGN) Just Reported Earnings, And Analysts Cut Their Target Price
• 13 mai ·

  Yahoo
  UroGen Pharma Ltd (URGN) Q1 2025 Earnings Call Highlights: Strong Jelmyto Sales and Promising ...
• 12 mai ·

  SeekingAlpha
  UroGen Pharma Ltd. (URGN) Q1 2025 Earnings Call Transcript